Skip to main content
logo
Lycia Therapeutics, Inc. (LYCA)
Lycia Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Lycia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '25 Dec '24
Cash & Equivalents
60.9419.2730.59
Short-Term Investments
63.3859.85107.43
Cash & Cash Equivalents
124.3279.12138.02
Cash Growth
--42.67%-
Other Current Assets
3.41.511.81
Total Current Assets
127.7280.63139.83
Property, Plant & Equipment
-1.713.27
Long-Term Investments
-12.073.01
Goodwill and Intangibles
-2.644.63
Other Long-Term Assets
-0.160.18
Total Long-Term Assets
-16.5811.08
Total Assets
-97.22150.91

Liabilities

Year Ending
TTMDec '25 Dec '24
Accounts Payable
-12.27
Deferred Revenue
-1.021.85
Current Debt
-1.021.85
Other Current Liabilities
10.14--1.23
Total Current Liabilities
10.14-4.74
Long-Term Debt
-6.4923.33
Other Long-Term Liabilities
--4.76-20.4
Total Long-Term Liabilities
-1.732.92
Total Liabilities
-8.2126.5

Shareholders' Equity

Year Ending
TTMDec '25 Dec '24
Retained Earnings
--117.56-81.1
Comprehensive Income
-0.10.25
Shareholders' Equity
-132.14-113.34-77.93

Additional Metrics

Year Ending
TTMDec '25 Dec '24
Total Debt
3.167.5125.18
Debt Growth
--70.18%-
Net Cash (Debt)
121.1671.61112.84
Net Cash (Debt) Growth
--36.54%-
Working Capital
117.5880.63135.09